Omalizumab: for severe ocular allergy

Omalizumab: for severe ocular allergy

Bibliographic Details
Main Authors:	Juliana Murata, Jessica Drobrzenski, Cintia Silva, Carlos Antonio Riedi, Herberto Jose Chong-Neto, Nelson Augusto Rosario
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	World Allergy Organization Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S1939455120301794

Similar Items

Epidemiology of ocular allergy and co-morbidities in adolescents
by: Marcos Geraldini, et al.
Published: (2013-07-01)

Epidemiology of ocular allergy and co-morbidities in adolescents
by: Marcos Geraldini, et al.
Published: (2013-07-01)

Epidemiologia da alergia ocular e comorbidades em adolescentes
by: Marcos Geraldini, et al.
Published: (2013-08-01)

OMALIZUMAB IN TREATMENT FOR ALLERGIES
by: T.V. Kulichenko
Published: (2007-08-01)

OMALIZUMAB IN TREATMENT FOR ALLERGIES
by: T.V. Kulichenko
Published: (2007-08-01)

Immunotherapy and Oral Immunotherapy with Omalizumab for Food Allergies
by: Shoichiro Taniuchi, et al.
Published: (2019-12-01)

Severe asthma and the omalizumab option
by: Johnston Chambless, et al.
Published: (2008-05-01)

Ocular allergy
by: Khathutshelo P. Mashige
Published: (2017-10-01)

Efficacy of long-term treatment with omalizumab in a food and inhalant allergy patient
by: Eleonora Nucera, et al.
Published: (2020-07-01)

Review: Omalizumab in the treatment of severe asthma: efficacy and current problems
by: Girolamo Pelaia, et al.
Published: (2008-12-01)

Omalizumab for the treatment of severe persistent allergic asthma
by: J Jones, et al.
Published: (2009-09-01)

A review of omalizumab for the management of severe asthma
by: Lin CH, et al.
Published: (2016-07-01)

Omalizumab Treatment in Patients with Severe Allergic Asthma
by: Tuğba Songül Tat, et al.
Published: (2017-09-01)

The Role of Omalizumab in the Treatment of Severe Allergic Asthma
by: Kenneth R Chapman, et al.
Published: (2006-01-01)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
by: C. C. Loureiro, et al.
Published: (2018-01-01)

Ocular allergy and keratoconus
by: Namrata Sharma, et al.
Published: (2013-01-01)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
by: S. M. Snelder, et al.
Published: (2017-07-01)

Utility of Asthma Control Questionnaire 7 in the assessment of asthma control
by: Mariana Nadal Cardoso, et al.
Published: (2014-04-01)

In vitro basophil activation is reduced by short-term omalizumab treatment in hydrolyzed wheat protein allergy
by: Yuko Chinuki, et al.
Published: (2020-04-01)

Sibilância no lactente: epidemiologia, investigação e tratamento Wheezing in infancy: epidemiology, investigation, and treatment
by: Herberto José Chong Neto, et al.
Published: (2010-06-01)

Fatores de risco para sibilância no primeiro ano de vida Risk factors for wheezing in the first year of life
by: Herberto José Chong Neto, et al.
Published: (2008-12-01)

O uso de corticosteroide oral para sibilância em lactentes é abusivo? Are oral corticosteroids being used excessively in the treatment of wheezing in infants?
by: Herberto José Chong Neto, et al.
Published: (2011-02-01)

Expandindo a aplicação de questionário padronizado para sibilância recorrente no lactente Expanding the application of a standardized questionnaire on recurrent wheezing in infancy
by: Herberto José Chong Neto, et al.
Published: (2009-04-01)

Appropriate selection for omalizumab treatment in patients with severe asthma?
by: Leo Nygaard, et al.
Published: (2017-01-01)

Omalizumab in patients with severe asthma and persistent sputum eosinophilia
by: Manali Mukherjee, et al.
Published: (2019-04-01)

Benefits of omalizumab on anxiety and depression in patients with severe asthma
by: Fatih Uzer, et al.
Published: (2018-05-01)

The role of omalizumab in the treatment of adults with severe allergic asthma
by: Sabina Škrgat Kristan
Published: (2013-02-01)

Respiratory allergy to moth: the importance of sensitization to Bombyx mori in children with asthma and rhinitis ,
by: Laura M.L. Araujo, et al.
Published: (2014-04-01)

Respiratory allergy to moth: the importance of sensitization to Bombyx mori in children with asthma and rhinitis
by: Laura M.L. Araujo, et al.
Published: (2014-03-01)

Respiratory allergy to moth: the importance of sensitization to Bombyx mori in children with asthma and rhinitis
by: Laura M.L. Araujo, et al.
Published: (2014-03-01)

Updates in the treatment of ocular allergies
by: Osmo Kari, et al.
Published: (2010-11-01)

Ocular allergy latin american consensus
by: Myrna Serapião dos Santos, et al.
Published: (2011-12-01)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
by: Giulia Scioscia, et al.
Published: (2020-03-01)

Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
by: Barrios Jonathan, et al.
Published: (2011-11-01)

Omalizumab in children with severe allergic disease: a case series
by: Giuseppe Crisafulli, et al.
Published: (2019-01-01)

Treatment of Severe Cold Contact Urticaria with Omalizumab: Case Reports
by: Petra Brodská, et al.
Published: (2012-12-01)

Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis
by: C. Incorvaia, et al.
Published: (2016-01-01)

Cluster Subanalysis of Patients With Severe Asthma Who Responded to Omalizumab
by: Almonacid Sánchez, C., et al.
Published: (2022)

Cutaneous Sarcoidosis in a Patient with Severe Asthma treated with Omalizumab
by: Samuel Yung, et al.
Published: (2015-01-01)

Rhinitis is also Common in Infants with Asthma
by: Herberto José Chong Neto, et al.
Published: (2010-03-01)